We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-7.16%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$3.97B
AUM Growth
-$499M
Cap. Flow
-$86.7M
Cap. Flow %
-2.18%
Top 10 Hldgs %
7.73%
Holding
1,278
New
86
Increased
451
Reduced
486
Closed
106

Top Buys

Rank Stock Value
1
SDRL icon
Seadrill
SDRL
+$12.9M
2
KMT icon
Kennametal
KMT
+$12.6M
3
VVX icon
V2X
VVX
+$11M
4
BTU icon
Peabody Energy
BTU
+$10.8M
5
WERN icon
Werner Enterprises
WERN
+$10.4M

Sector Composition

Rank Sector Weight
1 Financials 29.14%
2 Industrials 12.03%
3 Consumer Discretionary 11.43%
4 Technology 10.07%
5 Energy 9.52%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ARMP icon
1101
Armata Pharmaceuticals
ARMP
$173M
$65.2K ﹤0.01%
44,682
-25,000
-36% -$49.8K
CABA icon
1102
Cabaletta Bio
CABA
$455M
$63.3K ﹤0.01%
45,675
-42,000
-48% -$89.5K
ANRO icon
1103
Alto Neuroscience
ANRO
$1.11B
$62.9K ﹤0.01%
+29,100
New +$104K
JBIO
1104
Jade Biosciences
JBIO
$1.34B
$62.8K ﹤0.01%
714
-1,000
-58% -$87.8K
UAMY icon
1105
United States Antimony
UAMY
$1.02B
$61.2K ﹤0.01%
+27,800
New +$48.2K
RLYB icon
1106
Rallybio
RLYB
$85.8M
$60K ﹤0.01%
11,450
HYLN icon
1107
Hyliion Holdings
HYLN
$690M
$59.5K ﹤0.01%
42,500
DTI icon
1108
Drilling Tools International
DTI
$80.1M
$59.3K ﹤0.01%
+25,000
New +$77.3K
LITS
1109
Lite Strategy Inc
LITS
$30.9M
$58.8K ﹤0.01%
26,869
BSIN
1110
Big Sky Industrial
BSIN
$63.3M
$58.6K ﹤0.01%
48,848
RANI icon
1111
Rani Therapeutics
RANI
$89M
$58.6K ﹤0.01%
46,500
-10,000
-18% -$14.8K
IPSC icon
1112
Century Therapeutics
IPSC
$361M
$57.4K ﹤0.01%
120,500
-129,200
-52% -$97.1K
GANX icon
1113
Gain Therapeutics
GANX
$77.6M
$57.3K ﹤0.01%
30,004
NINE
1114
DELISTED
Nine Energy Service
NINE
$56.5K ﹤0.01%
50,000
-42,700
-46% -$52.4K
MAIA icon
1115
MAIA Biotechnology
MAIA
$86.3M
$55.1K ﹤0.01%
36,000
-9,700
-21% -$18K
GTEC icon
1116
Greenland Technologies Holding
GTEC
$14.3M
$52.5K ﹤0.01%
+30,000
New +$56.3K
UBX
1117
DELISTED
Unity Biotechnology
UBX
$52K ﹤0.01%
50,000
NNVC icon
1118
NanoViricides
NNVC
$36.2M
$51.5K ﹤0.01%
44,039
XLO icon
1119
Xilio Therapeutics
XLO
$60.3M
$51.5K ﹤0.01%
5,077
HBIO icon
1120
Harvard Bioscience
HBIO
$29.2M
$50.7K ﹤0.01%
8,952
-3,980
-31% -$51K
PSQH icon
1121
PSQ Holdings
PSQH
$14.7M
$50.4K ﹤0.01%
1,467
OCC icon
1122
Optical Cable Corp
OCC
$143M
$49.1K ﹤0.01%
17,600
-10,000
-36% -$42.8K
CLRO icon
1123
ClearOne Inc
CLRO
$27.2M
$47.5K ﹤0.01%
5,454
SIF icon
1124
SIFCO Industries
SIF
$176M
$46K ﹤0.01%
16,674
IRWD icon
1125
Ironwood Pharmaceuticals
IRWD
$714M
$45.6K ﹤0.01%
31,000

Similar funds

Bridgeway Capital Management's Q1 2025 Portfolio in Review

As of Q1 2025, Bridgeway Capital Management held 1,278 positions worth $3.97B, down 11% from $4.47B the previous quarter. Its ten largest holdings account for 7.7% of the portfolio.

Bridgeway Capital Management's Q1 2025 filing shows 86 new, 451 increased, 486 reduced and 106 closed positions. Its largest new stake was Seadrill: 415,580 shares worth $10.4M. The largest sale was Patrick Industries, an estimated $19.9M.

By sector, the portfolio is most concentrated in Financials at 29% of assets, up from 28% a quarter earlier, followed by Industrials and Consumer Discretionary.

  • Bridgeway Capital Management's largest Q1 2025 buy was Seadrill: 415,580 shares worth $10.4M.
  • Bridgeway Capital Management added most to Hamilton Insurance Group in Q1 2025, an estimated $9.08M increase.
  • Bridgeway Capital Management's biggest Q1 2025 reduction was EchoStar, cutting an estimated $13.9M.
  • Bridgeway Capital Management fully exited Patrick Industries in Q1 2025, selling an estimated $19.9M.
  • Bridgeway Capital Management's ten largest holdings make up 7.7% of its $3.97B portfolio in Q1 2025.
  • Bridgeway Capital Management opened 86 new positions and closed 106 in Q1 2025.
  • Bridgeway Capital Management's portfolio value fell 11% quarter-over-quarter to $3.97B.

Based on Bridgeway Capital Management's 13F filing for Q1 2025, filed 15 May 2025.